Details of the Drug

General Information of Drug (ID: DM1RAIS)

Drug Name

NEXI-002

Indication

Disease Entry	ICD 11	Status	REF
Multiple myeloma	2A83	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04505813) Antigen-specific T Cell Therapy for Patients With Relapsed Refractory Multiple Myeloma. U.S. National Institutes of Health.